Biomarker-directed therapeutics that restore plasma gelsolin — a protein replacement biologic designed to localize inflammation and prevent inflammatory dysregulation. Intended for patients with severe systemic inflammation, including sepsis, trauma, burns, renal disease and select orphan indications.